Leerink Partners Forecasts Strong Price Appreciation for Pediatrix Medical Group (NYSE:MD) Stock

Pediatrix Medical Group (NYSE:MD – Get Free Report) had its price objective lifted by Leerink Partners from $14.50 to $17.00 in a note issued to investors on Friday,Benzinga reports. The firm presently has a “market perform” rating on the stock. Leerink Partners’ price objective points to a potential downside of 0.32% from the stock’s previous […]

Leave a Reply

Your email address will not be published.

Previous post Corebridge Financial Inc. Cuts Stake in Trupanion, Inc. $TRUP
Next post Sentencing looms for girlfriend of Burnsville first responders shooter. Could her straw purchasing have been stopped?